In a rare move, an advisory FDA panel voted 14-1 Oct. 19 in support of retracting Makena, the only treatment approved to help prevent preterm birth, from the market, which the agency fast-tracked and approved in 2011.
Read the full post on Becker's Hospital Review - Healthcare News
